Yamamoto M - Search Results

1

LRRK2 P755L variant in sporadic Parkinson's disease.

Tomiyama H, Mizuta I, Li Y, Funayama M, Yoshino H, Li L, Murata M, Yamamoto M, Kubo SI, Mizuno Y, Toda T, Hattori N. Tomiyama H, et al. Among authors: yamamoto m. J Hum Genet. 2008;53(11-12):1012-1015. doi: 10.1007/s10038-008-0336-5. Epub 2008 Oct 16. J Hum Genet. 2008. PMID: 18923807

2

[A guideline for the treatment of Parkinson's disease].

Miziuno Y, Okuma Y, Kikuchi S, Kuno S, Hashimoto T, Hasegawa K, Mano Y, Miwa H, Murata M, Yamamoto M, Yokochi F, Okiyama R, Kanazawa A, Shinpo K, Chuma T, Higashi T, Maruyama T, Mizuta E, Yamazaki S; Ad Hoc Committee on the Guidelines for the Treatment of Parkinson's Disease, Japanese Neurological Society. Miziuno Y, et al. Among authors: yamamoto m. Rinsho Shinkeigaku. 2002 May;42(5):421-94. Rinsho Shinkeigaku. 2002. PMID: 12708433 Review. Japanese. No abstract available.

3

Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.

Mizuno Y, Yanagisawa N, Kuno S, Yamamoto M, Hasegawa K, Origasa H, Kowa H; Japanese Pramipexole Study Group. Mizuno Y, et al. Among authors: yamamoto m. Mov Disord. 2003 Oct;18(10):1149-56. doi: 10.1002/mds.10508. Mov Disord. 2003. PMID: 14534919 Clinical Trial.

4

Toward identification of susceptibility genes for sporadic Parkinson's disease.

Toda T, Momose Y, Murata M, Tamiya G, Yamamoto M, Hattori N, Inoko H. Toda T, et al. Among authors: yamamoto m. J Neurol. 2003 Oct;250 Suppl 3:III40-3. doi: 10.1007/s00415-003-1307-6. J Neurol. 2003. PMID: 14579123

5

[Depression in Parkinson's disease].

Yamamoto M. Yamamoto M. Nihon Rinsho. 2004 Sep;62(9):1661-6. Nihon Rinsho. 2004. PMID: 15462381 Review. Japanese.

6

Session 3 "Analyzer Workshop" evolution of therapeutic strategies in Parkinson's disease.

Yanagisawa N, Yamamoto M, Kikuchi S, Murata M, Ohkuma Y. Yanagisawa N, et al. Among authors: yamamoto m. J Neurol. 2004 Oct;251 Suppl 7:vII24-30. doi: 10.1007/s00415-004-1707-2. J Neurol. 2004. PMID: 15505751 No abstract available.

7

Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.

Mizuta I, Satake W, Nakabayashi Y, Ito C, Suzuki S, Momose Y, Nagai Y, Oka A, Inoko H, Fukae J, Saito Y, Sawabe M, Murayama S, Yamamoto M, Hattori N, Murata M, Toda T. Mizuta I, et al. Among authors: yamamoto m. Hum Mol Genet. 2006 Apr 1;15(7):1151-8. doi: 10.1093/hmg/ddl030. Epub 2006 Feb 24. Hum Mol Genet. 2006. PMID: 16500997

8

Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients.

Mizuno Y, Kanazawa I, Kuno S, Yanagisawa N, Yamamoto M, Kondo T. Mizuno Y, et al. Among authors: yamamoto m. Mov Disord. 2007 Jan;22(1):75-80. doi: 10.1002/mds.21218. Mov Disord. 2007. PMID: 17094103 Clinical Trial.

9

Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population.

Funayama M, Li Y, Tomiyama H, Yoshino H, Imamichi Y, Yamamoto M, Murata M, Toda T, Mizuno Y, Hattori N. Funayama M, et al. Among authors: yamamoto m. Neuroreport. 2007 Feb 12;18(3):273-5. doi: 10.1097/WNR.0b013e32801254b6. Neuroreport. 2007. PMID: 17314670

10

Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population.

Satake W, Mizuta I, Suzuki S, Nakabayashi Y, Ito C, Watanabe M, Takeda A, Hasegawa K, Sakoda S, Yamamoto M, Hattori N, Murata M, Toda T. Satake W, et al. Among authors: yamamoto m. Neuroreport. 2007 Jun 11;18(9):937-40. doi: 10.1097/WNR.0b013e328133265b. Neuroreport. 2007. PMID: 17515805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,045 results

Search Page